What is Psychedelic Science Org UK?

Psychedelic Science Org UK is a crowd-funding campaign that aims to raise funds for scientific research with psychedelic drugs, with a special focus on a clinical trial assessing the safety and efficacy of psilocybin as a treatment for depression.


Depression is a serious global problem. It’s the leading cause of disability worldwide, is linked to over half of all suicides, and affects some 350 million people. Worse still, the prevalence of depression is increasing; the World Health Organisation estimates that depression will become the leading overall contributor to the global burden of disease by 2030.


Psilocybin changes brain activity in a manner that is consistent with a large range of effective treatments for depression. More specifically, we found that circuits that are over-active and reinforced in depression become loosened and normalised under psilocybin. Psilocybin works to mimic some serotonin actions. That psilocybin does this, may explain why it may be useful in depression.

Help Us

All research depends on funding and if the funds aren’t there, the research simply can’t happen.So, if you believe in our vision and conviction to try and improve the lives of patients suffering from depression, then please give us your support! This is an incredibly worthwhile cause and we are perfectly placed to deliver on it.

Our Story

In 2012, Imperial College London were awarded a research grant from the UK government’s Medical Research Council (MRC) to set-up a clinical trial to investigate the antidepressant potential of psilocybin. The study is sponsored by Imperial College London and has ethical approval. The UK Home Office have licensed the importation and storage of the psilocybin that we will use.

Our Founders

Key Staff
Dr Robin Carhart Harris (Founder)
Post-doctoral Researcher, Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London
Professor David Nutt
David Nutt (Founder) is currently the Edmond J Safra Professor of Neuropsychopharmacology and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences.

Research Background Videos

Latest Posts